P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 Antoni, MH, Cruess, DG, Klimas, N, Maher, K, Cruess, S, Kumar, M, Lutgendorf, S, Ironson, G, Schneiderman, N, and Fletcher, MA. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional näive T cells (CD4(+)CD45RA(+)CD29(+)). American Journal of Psychiatry 159:143-45, 2002. Kumar, M, Kumar, AM, Waldrop, D, Antoni, MH, Schneiderman, N, and Eisdorfer, C. The HPA axis in HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes 31 (2 Supplement):S89-93, 2002. Williams, R, Schneiderman, N, Relman, A, and Angell, M. Resolved: psychosocial interventions can improve clinical outcomes in organic disease—rebuttals and closing arguments. Psychosomatic Medicine 64:564-67, 2002. Williams, RB and Schneiderman, N. Resolved: psychosocial interventions can improve clinical outcomes in organic disease (pro). Psychosomatic Medicine 64:552-57, 2002. Kline, KA, Saab, PG, Llabre, MM, Spitzer, SB, Evans, JD, McDonald, PA, and Schneiderman, N. Hemodynamic response patterns: responder type differences in reactivity and recovery. Psychophysiology 39:739-46, 2002. Perna, FM, Antoni, MH, Baum, A, Gordon, P, and Schneiderman, N. Cognitive behavioral stress management effects on injury and illness among competitive athletes: a randomized clinical trial. Annals in Behavioral Medicine 25:66- 73, 2003. Cruess, DG, Antoni, MH, Gonzalez, J, Fletcher, MA, Klimas, N, Duran, R, Ironson, G, and Schneiderman, N. Sleep disturbance mediates the association between psychological distress and immune status among HIV-positive men and women on combination antiretroviral therapy. Journal of Psychosomatic Research 54:185-89, 2003. Motivala, SJ, Hurwitz, BE, Llabre, MM, Klimas, NG, Fletcher, MA, Antoni, MH, LeBlanc, WG, and Schneiderman, N. Psychological distress is associated with decreased memory helper T-cell and B-cell counts in pre-AIDS HIV seropositive men and women but only in those with low viral load. Psychosomatic Medicine 65:627-35, 2003. O’Cleirigh, C, Ironson, G, Antoni, M, Fletcher, MA, McGuffey, L, Balbin, E, Schneiderman, N, and Solomon, G. Emotional expression and depth processing of trauma and their relation to longterm survival in patients with HIV/AIDS. Journal of Psychosomatic Research 54:225-35, 2003. Lechner, SC, Antoni, MH, Lydston, D, LaPerriere, A, Ishii, M, Devieux, J, Ironson, G, Schneiderman, N, Brondolo, E, Tobin, J, and Weiss, S. Cognitive-behavioral interventions improve quality of life in women with AIDS. Journal of Psychosomatic Research 54, 253-61, 2003. Penedo, FJ, Gonzalez, JS, Dahn, JR, Antoni, M, Malow, R, Costa, P, and Schneiderman, N. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. Journal of Psychosomatic Research 54:271-78, 2003. Penedo, FJ, Gonzalez, JS, Davis, C, Dahn, J, Antoni, MH, Ironson, G, Malow, R, and Schneiderman, N. Coping and psychological distress among symptomatic HIV+ men who have sex with men. Annals of Behavioral Medicine 25:203-13, 2003. Penedo, FJ, Dahn, JR, Gonzalez, JS, Molton, I, Carver, CS, Antoni, MH, Roos, BA, and Schneiderman, N. Perceived stress management skill mediates the relationship between optimism and positive mood following radical prostatectomy. Health Psychology 22:220-22, 2003. UM/<strong>Sylvester</strong> <strong>Comprehensive</strong> <strong>Cancer</strong> <strong>Center</strong> Scientific Report <strong>2004</strong> 183
P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 Treiber, FA, Kamarck, T, Schneiderman, N, Sheffield, D, Kapuku, G, and Taylor, T. Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosomatic Medicine 65:46-62, 2003. Berkman, LF, Blumenthal, J, Burg, M, Carney, RM, Catellier, D, Cowan, MJ, Czajkowski, SM, DeBusk, R, Hosking, J, Jaffe, A, Kaufmann, PG, Mitchell, P, Norman, J, Powell, LH, Raczynski, JM, and Schneiderman, N. Enhancing recovery in coronary heart disease patients investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. Journal of the American Medical Association 289:3106-16, 2003. Watkins, LL, Schneiderman, N, Blumenthal, JA, Sheps, DS, Catellier, D, Taylor, CB, and Freedland, KE. ENRICHD Investigators. Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. American Heart Journal 146:48-54, 2003. Fernander, AF, Durán, REF, Saab, PG, Llabre, MM, and Schneiderman, N. Assessing the reliability and validity of the John Henry Active Coping Scale in an urban sample of African Americans and White Americans. Ethnicity & Health 8:147-61, 2003. Kline, KA, Saab, PG, Llabre, MM, Spitzer, SB, Evans, JD, McDonald, PAG, and Schneiderman, N. Hemodynamic response patterns: responder type differences in reactivity and recovery. Psychophysiology 39:739-46, 2003. Shonukan, O, Bagayogo, I, McCrea, P, Chao, M, and Hempstead, B. Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin. Oncogene 22:3616-23, 2003. Miguez-Burbano, MJ, Pineda-Medina, L, Lecusay, R, Page, JB, Castillo, G, Burban, X, Rodriguez, A, Rodriguez, N, and Shor-Posner, G. Continued high risk behaviors in HIV infected drug abusers. Journal of Addictive Disorders 21:67-80, 2002. Shor-Posner, G , Miguez, MJ, Pineda, LM, Rodriguez, A, Ruiz, P, Castillo, G, Burbano, X, Lecusay, R, and Baum, M. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 29:169-73, 2002. Miguez-Burbano, MJ, Burbano, X, Rodriguez, A, Lecusay, R, Rodriguez, N, and Shor-Posner, G . Development of thrombocytosis in HIV+ drug users: impact of antiretroviral therapy. Platelets 13:183-85, 2002. Miguez, MJ, Burbano, X, Archer, H, and Shor- Posner, G. Limited impact of highly active antiretroviral therapy in thrombocytopenia. Journal of Acquired Immune Deficiency Syndromes 30:260-61, 2002. Miguez-Burbano, MJ, Navas, R, Forero, MG, Burbano, X, Rodriguez, N, and Shor-Posner, G . Evaluation of HIV prevention and counseling practices of obstetrician/gynecologists in Bogota, Colombia: impact on women’s knowledge and risk practices. AIDS Education and Prevention 14:72-80, 2002. Shor-Posner, G , Lecusay, R, Morales, G, Campa, A, and Miguez-Burbano, MJ. Neuroprotection in HIV-positive drug users: implications for antioxidant therapy. Journal of Acquired Immune Deficiency Syndromes 31 Supplement 2:S84-88, 2002. Burbano, X, Miguez-Burbano, MJ, McCollister, K, Zhang, G, Rodriguez, A, Ruiz, P, Lecusay, R, and Shor-Posner, G . Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clinical Trials 3:483-91, 2002. 184 UM/<strong>Sylvester</strong> <strong>Comprehensive</strong> <strong>Cancer</strong> <strong>Center</strong> Scientific Report <strong>2004</strong>
- Page 1 and 2:
S C I E N T I F I C R E P O R T 2 0
- Page 3 and 4:
I N T R O D U C T I O N A N D P R O
- Page 5 and 6:
I N T R O D U C T I O N A N D P R O
- Page 7 and 8:
I N T R O D U C T I O N A N D P R O
- Page 9 and 10:
I N T R O D U C T I O N A N D P R O
- Page 11 and 12:
L E A D E R S H I P MULTIDISCIPLINA
- Page 13 and 14:
L E A D E R S H I P EXTERNAL ADVISO
- Page 15 and 16:
C A N C E R P R E V E N T I O N A N
- Page 17 and 18:
C A N C E R P R E V E N T I O N A N
- Page 19 and 20:
C A N C E R P R E V E N T I O N A N
- Page 21 and 22:
C A N C E R P R E V E N T I O N A N
- Page 23 and 24:
C A N C E R P R E V E N T I O N A N
- Page 25 and 26:
C A N C E R P R E V E N T I O N A N
- Page 27 and 28:
C A N C E R P R E V E N T I O N A N
- Page 29 and 30:
C A N C E R P R E V E N T I O N A N
- Page 31 and 32:
C A N C E R P R E V E N T I O N A N
- Page 33 and 34:
C A N C E R P R E V E N T I O N A N
- Page 35 and 36:
C A N C E R P R E V E N T I O N A N
- Page 37 and 38:
C A N C E R P R E V E N T I O N A N
- Page 39 and 40:
C A N C E R P R E V E N T I O N A N
- Page 41 and 42:
C A N C E R P R E V E N T I O N A N
- Page 43 and 44:
C A N C E R P R E V E N T I O N A N
- Page 45 and 46:
C A N C E R P R E V E N T I O N A N
- Page 47 and 48:
C L I N I C A L O N C O L O G Y R E
- Page 49 and 50:
C L I N I C A L O N C O L O G Y R E
- Page 51 and 52:
C L I N I C A L O N C O L O G Y R E
- Page 53 and 54:
C L I N I C A L O N C O L O G Y R E
- Page 55 and 56:
C L I N I C A L O N C O L O G Y R E
- Page 57 and 58:
C L I N I C A L O N C O L O G Y R E
- Page 59 and 60:
C L I N I C A L O N C O L O G Y R E
- Page 61 and 62:
C L I N I C A L O N C O L O G Y R E
- Page 63 and 64:
C L I N I C A L O N C O L O G Y R E
- Page 65 and 66:
C L I N I C A L O N C O L O G Y R E
- Page 67 and 68:
C L I N I C A L O N C O L O G Y R E
- Page 69 and 70:
C L I N I C A L O N C O L O G Y R E
- Page 71 and 72:
C L I N I C A L O N C O L O G Y R E
- Page 73 and 74:
C L I N I C A L O N C O L O G Y R E
- Page 75 and 76:
C L I N I C A L O N C O L O G Y R E
- Page 77 and 78:
C L I N I C A L O N C O L O G Y R E
- Page 79 and 80:
T U M O R C E L L B I O L O G Y P R
- Page 81 and 82:
T U M O R C E L L B I O L O G Y P R
- Page 83 and 84:
T U M O R C E L L B I O L O G Y P R
- Page 85 and 86:
T U M O R C E L L B I O L O G Y P R
- Page 87 and 88:
T U M O R C E L L B I O L O G Y P R
- Page 89 and 90:
T U M O R C E L L B I O L O G Y P R
- Page 91 and 92:
T U M O R C E L L B I O L O G Y P R
- Page 93 and 94:
T U M O R C E L L B I O L O G Y P R
- Page 95 and 96:
T U M O R C E L L B I O L O G Y P R
- Page 97 and 98:
T U M O R C E L L B I O L O G Y P R
- Page 99 and 100:
T U M O R C E L L B I O L O G Y P R
- Page 101 and 102:
T U M O R C E L L B I O L O G Y P R
- Page 103 and 104:
T U M O R C E L L B I O L O G Y P R
- Page 105 and 106:
T U M O R C E L L B I O L O G Y P R
- Page 107 and 108:
T U M O R C E L L B I O L O G Y P R
- Page 109 and 110:
T U M O R C E L L B I O L O G Y P R
- Page 111 and 112:
T U M O R C E L L B I O L O G Y P R
- Page 113 and 114:
T U M O R C E L L B I O L O G Y P R
- Page 115 and 116:
T U M O R C E L L B I O L O G Y P R
- Page 117 and 118:
T U M O R I M M U N O L O G Y P R O
- Page 119 and 120:
T U M O R I M M U N O L O G Y P R O
- Page 121 and 122:
T U M O R I M M U N O L O G Y P R O
- Page 123 and 124:
T U M O R I M M U N O L O G Y P R O
- Page 125 and 126:
T U M O R I M M U N O L O G Y P R O
- Page 127 and 128:
T U M O R I M M U N O L O G Y P R O
- Page 129 and 130:
T U M O R I M M U N O L O G Y P R O
- Page 131 and 132:
T U M O R I M M U N O L O G Y P R O
- Page 133 and 134:
T U M O R I M M U N O L O G Y P R O
- Page 135 and 136:
T U M O R I M M U N O L O G Y P R O
- Page 137 and 138:
T U M O R I M M U N O L O G Y P R O
- Page 139 and 140:
T U M O R I M M U N O L O G Y P R O
- Page 141 and 142:
T U M O R I M M U N O L O G Y P R O
- Page 143 and 144:
V I R A L O N C O L O G Y P R O G R
- Page 145 and 146: V I R A L O N C O L O G Y P R O G R
- Page 147 and 148: V I R A L O N C O L O G Y P R O G R
- Page 149 and 150: V I R A L O N C O L O G Y P R O G R
- Page 151 and 152: V I R A L O N C O L O G Y P R O G R
- Page 153 and 154: V I R A L O N C O L O G Y P R O G R
- Page 155 and 156: V I R A L O N C O L O G Y P R O G R
- Page 157 and 158: S H A R E D R E S O U R C E S 3) La
- Page 159 and 160: S H A R E D R E S O U R C E S C E L
- Page 161 and 162: S H A R E D R E S O U R C E S D N A
- Page 163 and 164: S H A R E D R E S O U R C E S G E N
- Page 165 and 166: S H A R E D R E S O U R C E S I N F
- Page 167 and 168: S H A R E D R E S O U R C E S P O P
- Page 169 and 170: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 171 and 172: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 173 and 174: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 175 and 176: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 177 and 178: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 179 and 180: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 181 and 182: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 183 and 184: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 185 and 186: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 187 and 188: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 189 and 190: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 191 and 192: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 193 and 194: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 195: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 199 and 200: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 201 and 202: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 203 and 204: P U B L I C A T I O N S 2 0 0 2 - 2
- Page 205 and 206: G L O S S A R Y IFN—interferon IL